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Abstract
Background: The human immunodeficiency virus type 1 (HIV-1) favors integration in active genes
of host chromatin. It is believed that transcriptional interference of the viral promoter over the
endogenous gene or vice versa might occur with implications in HIV-1 post-integrative
transcriptional latency.
Results: In this work a cell line has been transduced with a HIV-based vector and selected for Tat-
inducible expression. These cells were found to carry a single silent integration in sense orientation
within the second intron of the HMBOX1 gene. The HIV-1 Tat transactivator induced the viral LTR
and repressed HMBOX1  expression independently of vector integration. Instead, single-cell
quantitative in situ hybridization revealed that allele-specific transcription of HMBOX1 carrying the
integrated provirus was not affected by the transactivation of the viral LTR in cis.
Conclusion: A major observation of the work is that the HIV-1 genome has inserted in genes that
are also repressed by Tat and this could be an advantage for the virus during transcriptional
reactivation. In addition, it has also been observed that transcription of the provirus and of the
endogenous gene in which it is integrated may coexist at the same time in the same genomic
location.
Background
Retroviruses, such as human immunodeficiency virus type
1 (HIV-1) require reverse transcription and integration
into host chromatin to establish a provirus as an obliga-
tory replication step. The choice of the integration site is a
crucial intermediate of the virus life cycle. The chromatin
context determines the efficiency of viral transcription and
is involved in the establishment of post-integrative
latency that is the major obstacle to HIV-1 eradication
with current antiviral therapies [1-3]. In addition, inser-
tion of a provirus in the human genome can cause several
adverse effects [4]. For example, insertion of the retrovirus
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close to a proto-oncogene may induce transformation of
the cell. Gene therapy approaches suffer most from these
effects and recently it has been demonstrated that the acti-
vation of an oncogene caused transformation in several
children treated with a therapeutic retroviral vector [5]. In
principle, insertion of an ectopic transcription unit within
a gene may also result either in disruption of exonic
sequences, introduction of alternative splicing or tran-
scriptional interference. Clearly, these negative effects
would increase in importance relative to the increasing
unbalance of the endogenous gene expression between
alleles.
Integration site selection by retroviruses is not sequence-
specific but also not random. HIV-1 favors integration
within active transcription units [6-8]. Additional features
are the requirement of host factors such as the lens epithe-
lium-derived growth factor LEDGF/p75 for efficient tar-
geting of active transcription units [9] and a DNA
substrate wrapped around nucleosomes. Indeed, integra-
tion of HIV-1 is linked to nucleosomal markers of active
transcription (H3/H4 acetylation, H3K4 methylation)
and negatively correlated with inhibitory modifications
(H3K27 trimethylation and DNA CpG methylation) [10].
Subtle differences in the integration site choice exist
among retroviruses. Murine leukemia virus (MLV) inte-
grates within highly active promoters at ± 5 kb from the
transcription start sites [7,11]. HIV-1 instead, although
also favoring active genes, does not show a preference for
promoter-proximal integration. Rather, the virus inserts
throughout the transcriptional unit with a bias towards
intronic sequences: this is the likely result of the greater
size of introns compared to exons within a gene [6].
A crucial aspect of HIV-1 pathogenesis is the control of
provirus transcription. In particular the ability of the virus
to maintain a reservoir of transcriptionally silent provi-
ruses in resting memory T cells for long periods of time.
Multiple mechanisms have been postulated to concur in
these processes. Host factors, for example, may be limiting
the activity of the Tat transactivator. Tat interacts with a
cis-acting RNA element (trans-activation-responsive
region; TAR) present at the 5' end of each viral transcript
[12]. Through this interaction, the protein activates HIV-1
transcription by promoting the assembly of transcription-
ally active complexes at the LTR through multiple protein-
RNA and protein-protein interactions [13]. Tat interacts
with the core RNA polymerase II [14,15], the TATA-bind-
ing protein associated factor (TAFII) [16], TFIIH [17], cyc-
lin-dependent protein kinase 7 [18], SP1 [19], nuclear
factor of activated T cells (NFAT) [20], several histone
acetyltransferases [21-23] and cyclin T1 [24]. On the other
hand, the chromatin context at the site of integration
should determine whether the provirus is transcription-
ally active, poised for activation or inactive [25]. Early
studies showed that latency involved integration into
regions of heterochromatin [26,27]. More recent system-
atic genome-wide analysis of the chromosomal features
negatively associated to HIV-1 transcription revealed that
low levels of LTR-driven expression correlated with inte-
gration in gene deserts and in centromeric heterochroma-
tin, but also in highly expressed cellular genes [28].
Furthermore, HIV-1 has been found in intronic regions of
actively transcribed genes in resting memory CD4+ cells
derived from patient on highly active antiretroviral treat-
ment [29]. The paradox of HIV-1 integration in active
genes while being transcriptionally silent requires molec-
ular investigation of the phenomenon. Unfortunately
most cellular models of HIV-1 post-integrative latency
harbor the provirus outside of transcribed genes [3]. In
this work a cell-line that carries a single repressed provirus
integrated within the active transcription unit of the
HMBOX1 gene has been generated. Tat-mediated induc-
tion of provirus transcription resulted in the inhibition of
HMBOX1  expression. However, this effect could be
ascribed to Tat expression and not to activation of the viral
LTR. Indeed, a subset of activated cells showed bi-allelic
expression of HMBOX1 together with expression of the
provirus within one of the alleles. These results are dis-
cussed in light both of HIV-1 pathogenesis and of the
potential use of lentiviral vectors for gene therapy applica-
tions.
Results
Generation and characterization of a cell line carrying a 
stably integrated lentiviral vector
The HIV-Intro-MS2 × 24-ECFPskl-IRES-TK lentiviral vec-
tor (for simplicity: HIV-Intro) has been engineered to con-
tain the elements required for RNA production: the 5'
LTR, the major splice donor (SD1), the packaging signal
Ψ, the RRE, the splice acceptor A7 and the 3' LTR that
drives 3'-end formation (Figure 1). The construct carries
also an array of 24 repeats of the MS2 phage coat protein
within the intron, to increase specific detection of nascent
mRNA, a reporter of gene expression (ECFP) fused to the
peroxisome localization signal Ser-Lys-Leu (skl) and the
selectable marker thymidine kinase (TK) of herpes sim-
plex type 1.
In order to characterize this construct extensively before
transduction, HeLa cells were transfected with plasmid
HIV-Intro together with a plasmid expressing a mono-
meric DsRed-tagged Tat Figure 2A, top panels). As
expected from previous studies showing transcribed nas-
cent RNA by MS2-tagging [30,31], bright yellow spots
appeared within the nucleus. Each spot corresponds to
several plasmids clustered together that express viral RNA
[32]. As expected, Tat was found at transcription sites
because it binds the 5'-end of each transcript. The reporter
of gene expression ECFPskl was found in the cytoplasm.Retrovirology 2008, 5:98 http://www.retrovirology.com/content/5/1/98
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When a plasmid expressing a DsRed-tagged Rev was co-
transfected together with Tat (without tag), the unspliced
RNA was found in the cytoplasm, consistent with its Rev-
mediated export (Figure 2A, bottom panels). These results
are mirrored by the behavior in RT-PCR using a set of
primers that distinguish pre-mRNA from spliced RNA. As
shown in figure 2B, basal transcription is up-regulated by
Tat with a higher proportion of spliced over unspliced
RNA. Co-transfection of a plasmid encoding pEYFP-
MS2nls does not affect the splicing reaction, ruling out
perturbation of the system by such a strong RNA binding
protein. Expression of Rev instead increased the propor-
tion of unspliced RNA, consistent with its role in RRE-
containing RNA stabilization and export.
A key question that arose while doing these experiments
was the real nature of these yellow spots in the nucleus
(Figure 2A, top panels). To confirm that these where sites
of HIV-Intro transcription we incubated the cells with
inhibitors such as Actinomicin D, α-Amanitin or Fla-
vopiridol. As shown in Figure 2C, a rapid decrease of the
number of transcription spots was observed with all three
inhibitors. Hence, RNA-dependent accumulation of RNA
at these sites was dependent on RNAPII activity.
Next a strategy was designed to express the HIV-Intro con-
struct from a single chromatinized location in a Tat-induc-
ible way. Osteosarcoma HOS_143b cells, that are negative
for thymidine kinase activity (TK-), were transduced with
the HIV-Intro vector pseudotyped with the VSV-G enve-
lope. To select for clones that carry an inducible integrated
provirus, cells that constitutively expressed high levels of
HSV-TK were selected against by treatment with 50 μg/ml
ganciclovir. Surviving cells, that were either non-trans-
duced, or transduced but with a low level of TK expres-
sion, were treated with GST-Tat and briefly selected for
inducible HSV-TK expression in hypoxanthine, aminop-
terin and thymidine (HAT) medium. Clonal populations
were obtained by limiting dilutions and colonies were vis-
ually scored for low basal level of ECFP expression in the
cytoplasm and to be highly inducible by GST-Tat by fluo-
rescence microscopy. The HOS_A4 cell clone showed a
robust and homogenous induction of ECFPskl in the cyto-
plasm upon treatment with GST-Tat (Figure 3A). These
Genomic organization of the HMBOX1 gene and of the HIV-intro construct in HOS_A4 cells Figure 1
Genomic organization of the HMBOX1 gene and of the HIV-intro construct in HOS_A4 cells. Position of the RT-
PCR primers are indicated by black arrows. Positions of the FISH probes are indicated by red bars.
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A) HeLa cells were cotransfected with pHIV-Intro, pEYFP-MS2nls and either mDsRed tagged Tat (top) or Tat and mDsRed  tagged Rev (bottom) Figure 2
A) HeLa cells were cotransfected with pHIV-Intro, pEYFP-MS2nls and either mDsRed tagged Tat (top) or Tat 
and mDsRed tagged Rev (bottom). Yellow spots in the nucleus correspond to nascent RNA from transfected plasmids. 
Cyan spots in the cytoplasm correspond to ECFPskl localized to peroxisomes. B) RT-PCR on HeLa cells transfected as indi-
cated. Three primers were used, their position is shown in Figure 1. Resulting bands correspond to the unspliced and spliced 
HIV-Intro RNAs. Bottom panels: β-actin loading control (M = molecular weight marker). C) Effect of RNAPII inhibitors on 
HIV-Intro transcription in transfected HeLa cells transfected as indicated in Figure 2A, top panels. Nuclei showing transcription 
spots were scored 1 hour (gray bars) an 6 hours (black bars) after treatment with Actinomicin D (10 μg/ml), α-Amanitin (10 
μg/ml) or Flavopiridol (500 μM).
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A) Generation of HOS_A4 cells by transduction with HIV-Intro and selection as described in the text Figure 3
A) Generation of HOS_A4 cells by transduction with HIV-Intro and selection as described in the text. Tat induc-
tion induced the expression of ECFPskl in the cytoplasm. Top panels: phase contrast. Bottom panels: ECFP channel. B) South-
ern blot analysis of HOS_A4 cells shows the presence of a single integration event. Genomic DNA was digested with XhoI or 
SpeI and hybridized with a probe encompassing ECFP. C) Effect of Tat-mDsRed on HOS_A4 cells. Co-localization of Tat and 
HIV-Intro RNA is shown on the single transcription spot present in HOS_A4 cells. Correct gene expression is demonstrated 
by the ECPFskl signal in the cytoplasm. D) Co-localization of RNAPII and Cyclin T1 on HOS_A4 transcription spots. Cells 
were transfected with pEYFP-MS2nls and Tat, fixed and Cyclin T1 (top panels) or RNAPII (bottom panels) detected by immun-
ofluorescence as described in [30].
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cells were transfected with plasmids encoding EYFP-
MS2nls and Tat-mDsRed. As shown in figure 3C, HOS_A4
showed ECFPskl in the cytoplasm and presented one sin-
gle bright yellow spot in the nucleus compatible with a
single site of HIV-Intro transcription that co-localized
with Tat-mDsRed. Immuonfluorescence with antisera
against Cyclin T1, the P-TEFb component recruited
directly by Tat on the viral RNA, or RNAPII demonstrated
enrichment of such factors at these sites (Figure 3D).
These results are compatible with one integration event of
the HIV vector in HOS_A4 cells. Indeed, analysis by
southern blotting (Figure 3B) and cloning of the integra-
tion sites by inverse PCR revealed that the provirus lay
within the HMBOX1 (homeobox containing 1) cellular
gene.
Allele-specific expression of HMBOX1 following HIV-
Intro-MS2 × 24-ECFPskl-IRES-TK transactivation
Human  HMBOX1  is composed of 11 exons, spanning
about 160 kb within chromosome 8 p21.1 (Figure 1).
HMBOX1 is believed to encode for a transcription factor
involved in the transcriptional regulation of key eukaryo-
tic developmental processes. HMBOX1  is widely
expressed in pancreas and the expression of this gene can
also be detected in pallium, hippocampus and hypothala-
mus [33]. In HOS_A4 cells the HIV-Intro lentiviral vector
integrated within the second giant intron of HMBOX1
(Figure 1). In order to assess expression of HMBOX1 in
HOS cells RT-PCR was performed with primers specific for
Exon3 or encompassing Exon2/Exon3 junction (Figure
4A). Both parental HOS 143b and HOS_A4 expressed
HMBOX1 at similar levels. However, this assay was nei-
ther quantitative nor specific for the HMBOX1 allele car-
rying the integrated vector. A similar approach was also
employed for the HIV-Intro transcript. As shown in Figure
4B, a basal level of HIV-Intro expression was detected in
HOS_A4 that could be up regulated by Tat transfection.
In order to detect allele-specific transcription in the
HMBOX1 locus carrying the integrated provirus a quanti-
tative RT-PCR was developed according to the protocol of
Han and collaborators [29]. As shown in the diagram of
Figure 1, RT-PCR primers were designed to detect also
HMBOX1 transcripts containing HIV sequences upstream
of the viral transcription start site. RNA from HOS_A4
cells was reverse-transcribed and the resulting cDNA was
amplified with two primers that share the HIV_RT primer.
HIV_UP5 amplifies only HIV-Intro sequences produced
as a result of transcription of HMBOX1 reading through
the HIV-Intro genome that is inserted into the gene.
Because the forward primer is located upstream of the
transcription start site and the reverse primer is located
downstream of the LTR, only RNA species initiating
upstream of the HIV-1 transcription start site could be
amplified. HIV_START instead is able to amplify any HIV-
Intro transcript that has initiated at the viral start site. To
prevent amplification from HIV-1 DNA, isolated RNA was
treated with DNase before RT-PCR. In addition, control
reactions from which RT was omitted were included in
each experiment and were invariably negative. A positive
control of HIV transactivation involved a set of primers for
the HIV-1 spliced RNA product (primers HIV_nuc and
HIV_spliced). PCR amplification was conducted in the
presence of the dye CyberGreen for relative quantification
of PCR products. Transfection of Tat induced HIV-1 tran-
scripts several folds with both primer sets detecting HIV-1
transcripts (Figure 4C and Figure 4D). This result is per-
fectly in line with the well-known Tat-transactivation of
the viral LTR and with RT PCR data shown in Figure
4B[34]. Allele-specific detection of HMBOX1 RNA instead
showed a marked decrease in response to Tat (Figure 4E).
This result would be explained by negative interference
with the expression of HMBOX1 due to activation of a
strong promoter embedded within the gene. However,
when the analysis was conducted on two primer sets spe-
cific for the HMBOX1  gene both in HOS_A4 and the
parental HOS_143b we realized that expression of
HMBOX1 was affected by the presence of Tat per se and
not by the activation of the viral LTR (Figure 4F and Figure
4G). This effect was not a general effect on transcription
since the GAPDH gene was not affected (Figure 4H).
Single-cell analysis of HMBOX1 and HIV-1 expression
Ensemble-averaged analysis such as RT-PCR that relies on
the evaluation of a number of cells does not allow distinc-
tion between expression of each HMBOX1 allele. In fact,
although we analyzed allele-specific expression of the
allele carrying the provirus, still we don't know whether
HMBOX1 expression was balanced between alleles or not.
In order to evaluate the simultaneous expression of both
HMBOX1  alleles and of the integrated provirus, tran-
scripts were detected by quantitative fluorescent in situ
RNA hybridization (FISH). The amount of RNA on the
transcription spot is determined by the rate of transcrip-
tion and the rate of RNA processing. At steady state it
could be derived from the intensity of the fluorescence sig-
nal compared with the intensity of the signal from a
known reference as described previously [30]. For this
purpose for each probe and each acquisition we prepared
a calibration curve spotting different amounts of probe on
a coverslip in a constant volume. The probes were
acquired and deconvoluted using the same conditions
used for the samples (see Methods). The z-projection sum
of all planes was averaged and this value represent the sig-
nal emitted by each amount of probe. Therefore, the
number of probes for each voxel (a volume pixel in a
three-dimensional image) could be calculated for each
point of the calibration curve. In the case of HIV-IntroRetrovirology 2008, 5:98 http://www.retrovirology.com/content/5/1/98
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A) RT-PCR analysis of HMBOX1 expression in parental HOS_143b and clone HOS_A4 using primers for HMBOX1 Exon 3 (79  bp, top panel) and Exon 2/Exon 3 splicing (86 bp, middle panel) Figure 4
A) RT-PCR analysis of HMBOX1 expression in parental HOS_143b and clone HOS_A4 using primers for 
HMBOX1 Exon 3 (79 bp, top panel) and Exon 2/Exon 3 splicing (86 bp, middle panel). Bottom panel: β-actin con-
trol (230 bp). B) RT-PCR analysis of HIV-Intro expression (280 bp top panel) in parental HOS_143b and clone HOS_A4 using 
primers HIV_SPLICED and HIV_NUC (Table 1). Bottom panel: β-actin control (M = molecular weight marker; T = hours after 
Tat induction). C-H) Quantitative RT PCR for HIV-Intro, HMBOX1 and GAPDH expression using the indicated primers shown 
in Figure 1 and Table 1. Each histogram is the mean of three experiments normalized for β-actin expression and corrected for 
primer efficiency (E = 10-1/slope).
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transcripts, the number of RNAs on the transcription spot
in the presence of Tat was calculated to be 17 ± 4.
HMBOX1 expression was low and could not be detected
by a single probe. Therefore a mixture of eight oligonucle-
otides, distributed in the first and fourth exon and in the
second intron before and after the integration (Figure 1),
were designed to detect the nascent unprocessed RNA
transcripts of HMBOX1 (Table 1). As shown in figure 5A,
in parental HOS-143b two spots of equal intensity were
clearly visible in 37.2% of nuclei indicating that the
HMBOX1 gene is expressed from both alleles, but only in
a fraction of the asynchronous population of cells. This is
not surprising since there is ample variation of the
number of alleles/nucleus detected by this method,
depending on how robust is gene expression and how effi-
cient is the processing of the RNA; both contribute to the
level of RNA at the site of transcription at steady state [35].
It is however unlikely that detection was lowered by scarce
accessibility of the probe to the RNA since positive cells
showed invariably two alleles of equal intensity, where in
the case of technical problems there would be a higher
proportion of single-allele expressing cells. The same was
observed in derivative HOS_A4 cells where 36.8% of
nuclei showed biallelic expression of the HMBOX1 gene
(Figure 5C). The number of nascent RNAs present on the
transcription site at steady-state was calculated to be sig-
nificantly similar in both cell lines: 4.13 ± 1.02 for
HOS_143b and 4.11 ± 0.91 for HOS_A4 (p value = 0.18)
(Figure 6B). Most importantly, the ratio between the
intensity of the signal of the two loci was invariably close
to 1 in both cell lines demonstrating bi-allelic expression
of the HMBOX1 gene with comparable levels (Figure 6C).
Next we investigated the effect of Tat transfection. Consist-
ently with what has been observed with RT PCR analysis,
the number of Tat-transfected nuclei showing expression
of the two HMBOX1 loci decreased (Figure 6A). This dif-
ference was significant in both cell lines (p value = 1.34 ×
10-23  for HOS_143b and p value = 2.63 × 10-4  for
HOS_A4). Interestingly, in those cells where both spots
were detected, the number of RNAs and the ratio of the
HMBOX1 alleles were not affected (Figure 6B and Figure
6C). HIV transcripts instead were present in most (93%)
of Tat-EGFP transfected cells, consistent with transactiva-
tion of the viral LTR in the clonal population (Figure 7).
Interestingly, most cells that express the vector do not
show expression of HMBOX1 in both alleles, indicating
that the effect on the expression of HMBOX1 was depend-
ent on the expression of Tat and not on the transactivation
of the provirus. Even more strikingly, in 11% of Tat-EGFP
transfected nuclei both HMBOX1 alleles and the proviral
transcript were active (Figure 7). In this subset of cells the
ratio between HMBOX1 alleles was also close to 1 and the
intensity of the proviral signal comparable to that of cells
where there was no HMBOX1  expression. In fact, as
shown in figure 6D, transcription of HIV-1 was not signif-
icantly affected by allele-specific HMBOX1 transcription
(p value = 0.91). Hence, there are conditions where intra-
genic transcription of HIV-1 can occur in the presence of
transcription of the host gene.
Discussion
Integration of HIV-1 in host chromatin is a crucial event
for viral pathogenesis. Chromatin control of provirus
gene expression has been postulated to be a major deter-
minant of post-integration latency that is the cause of fail-
ure to eradicate HIV-1 infection by current antiretroviral
regimens [1-3]. In addition, development of lentiviral vec-
tors for gene therapy requires that endogenous genes
shouldn't be affected by the integration event. However,
recent evidence suggests that down-modulation of HIV-1
expression occurs also within active genes, in the absence
of a repressive chromatin context. A cell line harboring a
Tat-inducible HIV-1 vector integrated within the
HMBOX1 endogenous gene has been engineered in this
work. This allowed the detailed investigation of the recip-
rocal influence of HIV-1 and HMBOX1 expression both
with or without Tat induction.
As a result of the double selection procedure, HOS_A4
showed a basal level of HIV-1 RNA by RT PCR that could
be assigned to HMBOX1  read-through transcription
across the silent HIV-1 provirus since neither RNA was evi-
dent in FISH (Figure 5C) nor ECFPskl could be detected in
the cytoplasm (Figure 3A). Tat overexpression, while
increasing HIV-1 expression as expected, also reduced the
level of expression of HMBOX1 in both alleles. Besides its
essential role in trans-activating HIV-1 transcription, Tat is
known to regulate key host cell functions, primarily at the
level of transcription. For example, Tat down-regulates
MHC class II by preventing the interaction of cyclin T1
with the class II transactivator CIITA [36]. It is conceivable
that Tat, being able to interact with a variety of host factors
required for HIV transactivation [13,37], at the same time
pulls these factors away from specific host genes, altering
transcription from these promoters. Genome-wide
expression profiling indeed revealed that Tat overexpres-
sion resulted in down-modulation of many cellular genes,
possibly through targeting of general factors such as the
SWI/SNF chromatin remodeling complex and the p300
acetyltransferase [38,39]. Hence, HMBOX1 adds to the list
of genes being down modulated by Tat overexpression. It
is possible that during the establishment of the HOS_A4
cell line there has been a positive selection of integration
loci where Tat induced repression of transcription. If
expression of the endogenous gene interferes in cis with
the expression of the provirus, the net result of Tat induc-
tion would have been of increased LTR-driven expression
due also in part to the decrease of HMBOX1 expression.Retrovirology 2008, 5:98 http://www.retrovirology.com/content/5/1/98
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A) FISH for HMBOX1 RNA on parental HOS_143b cells Figure 5
A) FISH for HMBOX1 RNA on parental HOS_143b cells. Top panel: large field image (bar = 10 μm). Bottom panels: 
single cell from the figure above (inset). Two distinct hybridization signals per nucleus demonstrate bi-allelic expression of the 
HMBOX1 gene. B) Same as A after transfection of Tat-EGFP. Also the signal for Tat-EGFP is shown (middle panels). Bottom 
panel: merge of HMBOX1 hybridization and Tat-EGFP expression. C) FISH for HIV-Intro RNA on HOS_A4 cells. Top panel: 
large field image (bar = 10 μm). Bottom panels: single cell from the figure above (inset). Absence of the hybridization signal with 
the HIV probe is due to silencing of the gene without Tat (left panels). Two distinct hybridization signals per nucleus demon-
strate bi-allelic expression of the HMBOX1 gene (middle panels).
HMBOX1 probes DAPI
A) HOS_143b
HMBOX1 probes Tat-EGFP DAPI
EGFP/Cy3 merge
B) HOS_143b + Tat
HMBOX1 probes HIV-1 probe DAPI
C) HOS_A4Retrovirology 2008, 5:98 http://www.retrovirology.com/content/5/1/98
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A) The number of cells expressing HMBOX1 in both loci before and after Tat-EGFP transfection is shown Figure 6
A) The number of cells expressing HMBOX1 in both loci before and after Tat-EGFP transfection is shown. B) 
The number of HMBOX1 RNAs on the transcription spots before and after Tat-EGFP transfection is shown. C) The ratio 
between the intensity of the hybridization signals on the transcription spots of the HMBOX1 alleles is shown. D) The intensity 
of the MS2 hybridization signal on HIV-Intro transcription spots is shown both on a HMBOX1 active and inactive background.
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However, the number of HIV-1 nascent RNAs in Tat-trans-
fected HOS_A4 cells that were negative for HMBOX1
expression was similar to the number of those where
instead HMBOX1 was active (Figure 6D).
Another important finding of this work was that in some
cells expression of the endogenous HMBOX1 gene and of
the provirus coexisted at the same transcription site. This
finding could not be anticipated since it was believed that
transcriptional interference should have occurred. Tran-
scriptional interference is the suppressive influence of one
transcriptional process directly and in cis, on a second
transcriptional process [40,41]. Several combinations of
the disposition of the two transcription units produce dif-
ferent effects [42]. For example, two promoters firing in
opposite orientation would end up in collision of the two
converging transcription elongation complexes. In
HOS_A4 cells instead, the two promoters elongate in the
same direction allowing a possible transcriptional inter-
ference through occlusion of the downstream promoter.
In such model transcription from the upstream HMBOX1
promoter should transiently preclude the occupation by
RNAPII and/or associated transcription factors of the
downstream LTR promoter. Alternatively, the LTR could
pose a roadblock to the progress of the transcription-elon-
gation complex firing from the HMBOX1 promoter result-
ing in its inhibition of expression from one allele.
The observation that in the absence of Tat transcription
both  HMBOX1  alleles were equally expressed while
expression from the viral LTR remained undetectable
might indicate that transcription elongation of RNAPII
across the HMBOX1 gene occluded the viral LTR. The sit-
uation changed dramatically in the presence of Tat. Tran-
scription from the viral LTR is switched on as shown in RT
PCR as well as demonstrated by the appearance of the
viral transcript in RNA FISH. As discussed previously, Tat
repressed HMBOX1  expression while allowing provirus
transcription. However, in a subset of cells, expression of
both genes coexisted. Recent data also analyzed HIV pro-
viral gene expression from within a cellular gene [43].
Work by Peterlin's group showed transcriptional interfer-
ence occurring from elongating polymerase firing from
the host gene [44], whereas work from Silicano's labora-
tory showed that elongating polymerase from the host
gene could enhance HIV transcription when orientated in
the same direction [45]. It is difficult to compare directly
these data with those presented here since different cell
lines and host cell genes were studied. However the find-
ings presented in this work show an alternative situation
that will require further analysis to understand the molec-
ular basis of the phenomenon.
Conclusion
In this work HIV-1 gene expression was studied from
within the endogenous gene HMBOX1. Transcriptional
Tat-transactivation of the viral LTR resulted in up-regula-
tion of HIV-1 transcription while it repressed HMBOX1
gene expression in both alleles, independent of vector
integration. Hence, it could be proposed that HIV-1
Table 1: Primers for RT-PCR and probes for RNA FISH used in this work.
Name Sequence 5' > 3'
PRIMERS FOR RT-PCR
HIV_UP5 GGCGAGCCCTCAGATCCTGC
HIV_START GGGTCTCTCTGGTTAGACCAGATCTGAGCC
HIV_RT AGTCGCCGCCCCTCGCCTCCTGC
HIV_SPLICED GGATTAACTGCGAATCGTTCTAGC
HIV_NUC CGTCTGTTGTGTGACTCTGGTAACT
HMBOX_E1s GTCTCTTTCCTCACTTCTTTCT
HMBOX_E1a TCACAGTTTCCAGAACTCCAC
HMBOX_E2s GGAATGGAACAGTGAAGAAGCA
HMBOX_E3s AATGGTAGATAACGCAGATCATC
HMBOX_E3a ACCACTGGAAAGGAACTAAGCA
PROBES FOR RNA FISH
HIV_MS2 AxGTCGACCTGCAGACAxGGGTGATCCTCAxGTTTTCTAGGCAATxA
HMBOX_E1a AxAGTTTCCAGAAxTCCACACCGGAGACCCCACxTCCAGGATTCAAACCxT
HMBOX_E1b CxCAGCGTCCGCxCACTTCCTCCCCAAAACCCCxCCAAAAAAATTGTTxT
HMBOX_I2a AxGGTTGGTATAAACACAxAAAGCATGGTGGTxGTCTGGAGCTGGGGTTxA
HMBOX_I2b AxTGCAGTGAGCCATGAxCACACCACAGTACxACAGCCTGGGTGATGAAxA
HMBOX_I2c AxATTGCTGTCCTAAxCAGACTGCACCTGTGGxGTGGCTCTGACTGGTxA
HMBOX_I2d AxGGTATGGTGGCAAAxCGACTCCCCCAGxACAACCACCAGAATATCAGxA
HMBOX_E4a AxACGCCGAAGTCGCxGAAGCAGATCTATCTGCxCTATGGTAAATCTGGxA
HMBOX_E4b AxATAACTGTTGCTAGGxGACGGGGACATTCCCGAAxGCTGCGTCTGTxA
Modified aminoallyl thymidines in the probes are indicated with "x". The sequence of one binding site for MS2 is underlined in the HIV_MS2 probe.Retrovirology 2008, 5:98 http://www.retrovirology.com/content/5/1/98
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FISH for HMBOX1 and HIV-Intro RNA on HOS_A4 cells after transfection of Tat-EGFP Figure 7
FISH for HMBOX1 and HIV-Intro RNA on HOS_A4 cells after transfection of Tat-EGFP. Merged images are 
shown in color both for the large fields and for the zoomed figures (bar = 10 μm).
HIV-1 probe DAPI
Cy3/Cy5 merge
HMBOX1 probes
Cy3/Cy5 merge
EGFP/Cy5 merge
EGFP/Cy5 merge
Tat-EGFP
HOS_A4 + tatRetrovirology 2008, 5:98 http://www.retrovirology.com/content/5/1/98
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genome insertion in genes repressed by Tat could be an
advantage for the virus allowing its transactivation from a
low-transcribing endogenous gene. It has also been
observed that both HIV-1 and HMBOX1 gene expression
may occur at the same genomic location in the same cell,
allowing speculation on the lack mutual interference
between transcription units.
Methods
Plasmids and cells
Plasmid pHIV-Intro was derived from the plasmid
pEV731 [27] by cloning 24 MS2 repeats into the NotI
restriction site. A cassette encoding for ECFP with the per-
oxisome localization signal Ser-Lys-Leu (skl) was inserted
between the ClaI and XhoI sites, the IRES from EMCV and
the thymidine kinase from HSV-1 were cloned in the XhoI
site [46]. To obtain cells transduced by the HIV-Intro len-
tiviral vector expressing the HSV-TK gene we exploited a
protocol for negative and positive selection of TK- cells.
HEK-293T cells were transfected with the vector plasmid
pHIV-Intro together with the packaging plasmids as previ-
ously described [26]. The supernatant was filtered and
used to transduce human bone osteosarcoma TK- cells
(HOS 143b, ECACC n. 91112502). Next day cells were
treated with ganciclovir at 50 μg/ml. Surviving cells were
expanded and then treated with 2.5 μg/ml of GST-Tat to
induce LTR expression as described previously [34,47].
The following day cells were incubated in hypoxanthine,
aminopterin and thymidine (HAT) medium and then
cloned by colony picking and expansion in complete
DMEM medium. Colonies were visually scored for low
basal level of ECFP expression and to be highly inducible
by GST-Tat by fluorescence microscopy. The number of
integrations was assessed by southern blotting with a
probe for ECFP and the cloning of the integration sites
was obtained by inverse PCR essentially as described [26].
Briefly, genomic DNA was digested with BamHI (cleavage
site within HIV-Exo-MS2 × 24), and the resulting products
were circularized with DNA ligase. The product of two
nested PCRs performed with primers pointing outwards
from the vector was cloned and sequenced.
Plasmids expressing Tat and MS2 have been described
previously [30,48]. Tat and Rev were fused to pDsRed-
Monomer-N1 (Clontech) by PCR.
Allele-specific RT-PCR
Total RNA was extracted as described by the kit (Qiagen,
RNA easy). Reverse transcription was performed with M-
MLV RT (Invitrogen) using random primers. Amplifica-
tion of the cDNA was conducted in the presence of Cyber-
Green™ (Applied Biosystems) and monitored on
AbiPrism 7000 (Applied Biosystems). Specific primers are
shown in Table 1.
Quantitative RNA fluorescent in situ hybridization (RNA 
FISH)
In situ hybridization was performed essentially as previ-
ously described [30]. Cells were fixed with 4% PFA pH7.4
and permeabilized overnight in 70% ethanol. Formamide
concentration was 40% for HMBOX1 probes and 20% for
MS2. The amino-allyl thymidine modified oligonucle-
otide probes (Table 1) have been synthesized by J-M
Escudier (Platforme de synthèse d'Oligonucléotides mod-
ifiés de l'Interface Chimie Biologie de l'ITAV, Toulouse,
France). Probes were labeled with Cy3 or Cy5 (Cyn mono-
reactive dye, Amersham). For quantitative measurements
stacks of 21 planes were acquired at bin = 2 with steps of
0.5  μm in the z-axis using a wide-field Leica DMRI
inverted microscope (63× objective, NA 1.3) controlled
by Metamorph (Universal Imaging). Digital images were
collected using a CoolSnap K CCD camera (Roper scien-
tific). The three-dimensional deconvolution and recon-
struction was performed with the ImageJ plug-in "Iterative
Deconvolve 3D". The total light intensity at the transcrip-
tion site was calculated and divided for the number of
planes and the number of molecule were computed from
a calibration curve of the probes in solution [30].
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